Metabolism and endocrinology

Maximizing the pricing and market access potential of new metabolism and endocrinology therapies

New mechanisms of action are an unmet need in the field of metabolic disease and endocrinology. However, the dominance of generic drugs in some indications creates price pressure for new entrants. A key consideration for manufacturers is therefore how to stratify large populations by risk, to target the new therapies where they can provide the greatest benefit.

 

In underserved indications, such as rare metabolic disorders, you need to develop innovative approaches to evidence generation and pricing. A tailored market access strategy is required for novel therapies.

 

Developing tailored pricing and market access strategies for metabolism and endocrinology therapies

 

Our strategic market access insight, pricing, and reimbursement expertise encompasses a range of indications, including:

  • diabetes
  • genetic disorders
  • hypercholesterolemia
  • osteoporosis.

Your tailored project will be led by members of our senior team. They like to be intellectually challenged and will be actively involved in your project, ensuring that your brief is integral to the work being conducted. They will tell you the whole story, and provide you with pragmatic, insightful, and clearly presented solutions.

 

We look forward to working with you on your market access challenges.

Request a call

The quality and breadth of your work is very impressive, particularly considering the timeframes you had to work with. Thank you for delivering everything so smoothly, on time, and on budget.

Director, Market Access and HEOR, top-10 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.